Government ❯ Regulatory Agencies ❯ FDA ❯ Drug Safety

Public Health

FDA to Remove Most Boxed Warnings From Menopause Hormone Therapies

New labeling prioritizes initiation before age 60 or within a decade of menopause.

FDA Issues New Warning on Unapproved Tianeptine 'Gas Station Heroin' Products